Draft guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues

  • Email
  • Help

Document details

Download document Draft guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues
Reference number EMEA/CHMP/BMWP/42832/2005 Rev. 1
Status draft: consultation closed
First published 2013-06-10
Last updated 2013-06-10

Summary

This guideline lays down the non-clinical and clinical requirements for a biological medicinal product claiming to be similar to another one already marketed ('biosimilar').